The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125757591 12575759 1 I 20160708 20160720 20160720 EXP PHHY2016HK097395 SANDOZ LAW MF, CHAN HN, PANG CY, LAI HK, HA CY, NG C, ET AL.. DURABLE SURVIVAL AFTER CHEMOTHERAPY IN A HIV PATIENT WITH BURKITT^S LYMPHOMA PRESENTING WITH MASSIVE UPPER GASTROINTESTINAL BLEEDING.. INTERNATIONAL JOURNAL OF STD + AIDS. 2016;27(8):690-96 39.00 YR M Y 0.00000 20160720 OT HK HK

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125757591 12575759 1 PS DOXORUBICIN DOXORUBICIN 1 Unknown U 200146
125757591 12575759 2 SS CYTARABINE. CYTARABINE 1 Unknown U 0
125757591 12575759 3 SS METHOTREXATE. METHOTREXATE 1 Unknown U 0
125757591 12575759 4 SS ETOPOSIDE. ETOPOSIDE 1 Unknown U 0
125757591 12575759 5 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown U 0
125757591 12575759 6 SS VINCRISTINE VINCRISTINE 1 Unknown U 0
125757591 12575759 7 SS PREDNISOLONE. PREDNISOLONE 1 Unknown U 0
125757591 12575759 8 SS IFOSFAMIDE. IFOSFAMIDE 1 Unknown U 0
125757591 12575759 9 C HYDROCORTISONE. HYDROCORTISONE 1 Unknown U 0
125757591 12575759 10 C LAMIVUDINE. LAMIVUDINE 1 Unknown U 0
125757591 12575759 11 C INDINAVIR INDINAVIR 1 Unknown U 0
125757591 12575759 12 C STAVUDINE. STAVUDINE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125757591 12575759 1 Burkitt's lymphoma stage IV
125757591 12575759 2 Burkitt's lymphoma stage IV
125757591 12575759 4 Burkitt's lymphoma stage IV
125757591 12575759 5 Burkitt's lymphoma stage IV
125757591 12575759 6 Burkitt's lymphoma stage IV
125757591 12575759 7 Burkitt's lymphoma stage IV
125757591 12575759 8 Burkitt's lymphoma stage IV
125757591 12575759 9 Product used for unknown indication
125757591 12575759 10 Product used for unknown indication
125757591 12575759 11 Product used for unknown indication
125757591 12575759 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125757591 12575759 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125757591 12575759 Diarrhoea haemorrhagic
125757591 12575759 Febrile neutropenia
125757591 12575759 Mucosal inflammation
125757591 12575759 Subcutaneous abscess

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found